CVE-2023-38559

Ghostscript: out-of-bound read in base/gdevdevn.c:1973 in devn_pcx_write_rle could result in dos

Description

A buffer overflow flaw was found in base/gdevdevn.c:1973 in devn_pcx_write_rle() in ghostscript. This issue may allow a local attacker to cause a denial of service via outputting a crafted PDF file for a DEVN device with gs.

Categories

5.5
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.01%
Vendor Advisory redhat.com Vendor Advisory redhat.com
Affected: Red Hat Red Hat Enterprise Linux 8
Affected: Red Hat Red Hat Enterprise Linux 9
Affected: Red Hat Red Hat Enterprise Linux 6
Affected: Red Hat Red Hat Enterprise Linux 7
Affected: Red Hat Red Hat Enterprise Linux 8
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2023-38559?
CVE-2023-38559 has been scored as a medium severity vulnerability.
How to fix CVE-2023-38559?
To fix CVE-2023-38559, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-38559 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-38559 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-38559?
CVE-2023-38559 affects Red Hat Red Hat Enterprise Linux 8, Red Hat Red Hat Enterprise Linux 9, Red Hat Red Hat Enterprise Linux 6, Red Hat Red Hat Enterprise Linux 7, Red Hat Red Hat Enterprise Linux 8.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.